Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolland C Dickson

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Transplantation Direct|December 16, 2020
Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis CChung Sang Tse, Ju Dong Yang, Omar Y Mousa, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survivalMarwan Ghabril, Rolland C Dickson, Victor I Machicao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experienceHani P Grewal, Darrin L Willingham, Justin Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis CDavid R Nelson, Vinod Rustgi, Vijayan Balan, et al.
Transplantation|January 16, 2004
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis CVictor I Machicao, Hugo Bonatti, Murli Krishna, et al.
Mayo Clinic Proceedings|August 12, 2006
Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantationWalter C Hellinger, Hugo Bonatti, Victor I Machicao, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2005
Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantationWalter C Hellinger, Hugo Bonatti, Joseph D Yao, et al.
Transplantation|July 20, 2002
A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantationWalter C Hellinger, Joseph D Yao, Salvador Alvarez, et al.
Clinical Transplantation|February 18, 2009
Long-term outcomes of donation after cardiac death liver allografts from a single centerJustin H Nguyen, Hugo Bonatti, Rolland C Dickson, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Transplantation Direct|December 16, 2020
Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis CChung Sang Tse, Ju Dong Yang, Omar Y Mousa, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survivalMarwan Ghabril, Rolland C Dickson, Victor I Machicao, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experienceHani P Grewal, Darrin L Willingham, Justin Nguyen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 9, 2008
Safety and antiviral activity of albinterferon alfa-2b in prior interferon nonresponders with chronic hepatitis CDavid R Nelson, Vinod Rustgi, Vijayan Balan, et al.
Transplantation|January 16, 2004
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis CVictor I Machicao, Hugo Bonatti, Murli Krishna, et al.
Mayo Clinic Proceedings|August 12, 2006
Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantationWalter C Hellinger, Hugo Bonatti, Victor I Machicao, et al.
Antiviral Therapy|March 8, 2006
A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapyVijayan Balan, David R Nelson, Mark S Sulkowski, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 26, 2005
Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantationWalter C Hellinger, Hugo Bonatti, Joseph D Yao, et al.
Transplantation|July 20, 2002
A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantationWalter C Hellinger, Joseph D Yao, Salvador Alvarez, et al.
Clinical Transplantation|February 18, 2009
Long-term outcomes of donation after cardiac death liver allografts from a single centerJustin H Nguyen, Hugo Bonatti, Rolland C Dickson, et al.
Pageof 5